Medarova, Zdravka
Pantazopoulos, Pamela
Yoo, Byunghee
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA16346101A1)
Article History
Received: 12 September 2019
Accepted: 22 January 2020
First Online: 6 February 2020
Competing interests
: Zdravka Medarova is Founder of TransCode Therapeutics, Inc.